As a legal and business journalist for almost 20 years, Mr Little has headed up titles across a range of industries, covering issues as diverse as not-for-profit sector management, the business applications of new technologies and risk management. From toshe worked as an international attorney in the international division of Thales former Thomson CSF. Before joining the European Patent Office, Mr van der Eijk was manager of the patent division and chief legal officer of the Netherlands Patent Office. Mr Luftman's areas of expertise are in delivering worldwide IP services to clients ranging from individual inventors and private start-up companies to global conglomerates. If this is your first time visiting the new LESI website, please follow these instructions to login for the first time:. Mr Berman works with businesses to frame and properly convey intangible assets, and to reach key audiences. He is chief executive at Steel City Re, a provider of headline risk mitigation solutions. Mr Haigh is a passionate writer and has written many articles for the marketing and financial press on branded businesses and brand valuation, and is the author of numerous publications. Please read below for instructions. She is a graduate of the University of Maine and earned her master's degree in library and information sciences from Simmons College in Boston.
Video: Glaxo tomasz filarski elisabeth BioBiz 2013: Glaxo Smith Kline
Thomas J Filarski, Licensing Executives Society (USA and Canada) Elisabeth Sussex, Proteus Biomedical, Director of Intellectual Property and IP Counsel . counsel at GlaxoSmithKline (GSK), where she served as the worldwide head of.
Elizabeth Carder Thompson Reed Smith. Washington DC GlaxoSmithKline in a patent infringement suit against Pfizer relat- . Thomas J Filarski. Steptoe &. Concord, Massachusetts. United States. Thomas Filarski Thomas Gallant.
Regional Director, Americas Elizabeth Gildea. Licensing Director.
He was also an adjunct professor at Seton Hall Law School. For your password, everyone has been assigned the temporary password of "Password1" After logging in, please click on "My Account" in the top right corner You will be prompted to change your password.
Suppression of Cyclooxygenase-2 Gene Transcription by Humulon. The program was developed with an emphasis on recent advances in molecular and of lipid mediators relevant in cellular mechanisims involved in the formation and actions inflammation and cancer. Welcome to the new LESI website. In that role, Mr Gill was a key policy official, responsible for the development and coordination of US IP policy and agency operations.
Glaxo tomasz filarski elisabeth
|Previously, he was the regional counsel, Asia Pacific and vice president, corporate staff, assistant general counsel at Texas Instruments to He is a veteran trial lawyer, having tried dozens of cases throughout the United States.
He draws upon a firm grasp of the fundamentals of IP theory to counsel clients ranging from established companies to inventors of disruptive technologies, from universities to governments, and from the developing world to first-world investors.
Parrett, M. From to Ms Knowles was senior vice president and chief patent counsel at GlaxoSmithKline GSKwhere she served as the worldwide head of patents for litigation and transactional matters, and managed a global department of over people in 12 offices.
John's patent cases have covered a wide range of technologies, including telecommunication networks, semiconductors, LCDs, consumer electronics and software.
In that role, Mr Gill was a key policy official, responsible for the development and coordination of US IP policy and agency operations.
IP Business Congress
Speaker: Thomas Bereuter, European Patent Office (EPO) Academy. G2: “Early Stage . Pam Demain. Tom Filarski. From left, Elisabeth Hess, Valerie Eder, Géraldine Müller-Stoy, Tilman Müller-Stoy and. Peter Hess.
Speaker: Thomas Bereuter, European Patent Office (EPO) Academy. G2: “Early Stage Pam Demain. Tom Filarski. Glaxo Wellcome Research and Development. Inovet Italia. Elizabeth D.
Video: Glaxo tomasz filarski elisabeth Bad Medicine: The Glaxo Case
Thuresson, Karen M. Lakkides, and WilJiam L. Smith. Uddhav Kelavkar, Cynthia Cohen, Thomas Eling, and Kamal Dadr. Kraus-Filarska, M., Malolepszy J., Medrala W.
and Dobek R. () Bacterial lipopolysaccharide- induced.
Leukotrienes and the Pulmonary Vascular Bed.
As a legal and business journalist for almost 20 years, Mr Little has headed up titles across a range of industries, covering issues as diverse as not-for-profit sector management, the business applications of new technologies and risk management. In that role, Mr Gill was a key policy official, responsible for the development and coordination of US IP policy and agency operations. Down-regulation of 5-lipoxygenase activity and leukotriene production by prolonged exposure to Lipopolysaccharide.
He represents companies in the pharmaceutical, medical device, biotechnology, chemical and electrochemical industries.
Glaxo tomasz filarski elisabeth
|Pytynia et al.
Calcium Binding to 5-Lipoxygenase. In his column, he explores the people, ideas and companies that are driving the region's innovation economy. In Mr Vilela was appointed a patent and trademark attorney. Both of these plenary lectures were held on Day 1, which set an exciting tone for this meeting. Mr Bernhard's insights and research embrace more than 20 years of telecommunications industry experience in segments such as broadband service generation, wireless carrier operations, public switched telephone network evolution and subscriber modelling across North American, European and Asian operators.